06:36 AM EST, 11/11/2026 (MT Newswires) -- Nexstim (NXTMH.HE) received an order to deliver its NBS 6 system to an undisclosed medical center in the US, according to a Wednesday release. The new client will use the technology, which includes motor mapping, speech mapping and therapy modules, for patient brain mapping and therapy, the Finnish medical technology company added.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.